[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples